91¿´Æ¬

+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

Leuprolide Acetate - Global Strategic Business Report - Product Thumbnail Image

Leuprolide Acetate - Global Strategic Business Report

  • Report
  • March 2026
  • 282 Pages
  • Global
From
From
Prostate Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Prostate Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
From
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 450 Pages
  • Global
From
Metastatic Prostate Cancer Market Report 2026 - Product Thumbnail Image

Metastatic Prostate Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Ipatasertib Market Report 2026 - Product Thumbnail Image

Ipatasertib Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Docetaxel Market Report 2026 - Product Thumbnail Image

Docetaxel Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Benign Prostatic Hyperplasia Treatment Market Report 2026 - Product Thumbnail Image

Benign Prostatic Hyperplasia Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Hormone Refractory Prostate Cancer Market Report 2026 - Product Thumbnail Image

Hormone Refractory Prostate Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Erleada Market Report 2026 - Product Thumbnail Image

Erleada Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Drugs for Benign Prostatic hypertrophy Market Report 2026 - Product Thumbnail Image

Drugs for Benign Prostatic hypertrophy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Leuprolide Acetate Market Report 2026 - Product Thumbnail Image

Leuprolide Acetate Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Androgen Deprivation Therapy Market Report 2026 - Product Thumbnail Image

Androgen Deprivation Therapy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Capecitabine Market Report 2026 - Product Thumbnail Image

Capecitabine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026 - Product Thumbnail Image

Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Prostate Cancer Diagnostics Market Report 2026 - Product Thumbnail Image

Prostate Cancer Diagnostics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more